Skip to content

Clinical Performance of Advanced Self- Adhesivee Resin Composite Hybrid Restorations.

Clinical Performance of Advanced Self-Adhesive Resin Composite Hybrid Restorations Versus Conventional Resin Composite Restorations in Posterior Teeth (1y Randomized Clinical Trial).

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790383
Enrollment
63
Registered
2021-03-10
Start date
2021-02-01
Completion date
2022-03-31
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries Class II, Caries,Dental

Keywords

self-Adhesive resin composite hybrid restorations, Posterior resin composite, Surefil One

Brief summary

Clinical performance according to modified USPHS criteria of advanced self-Adhesive resin composite hybrid restorations is evaluated for 1 year versus conventional resin composite restorations in posterior teeth.

Interventions

OTHERAdvanced Self-Adhesive resin composite hybrid restorations (Surefil one (Dentsply Sirona)).

Hybrid resin composite that doesn't need bonding system and releases calcium and flouride.

OTHERConventional resin composite restoration. (Sphere Tec, (Dentsply Sirona

Conventional Nanohybrid resin composite

Sponsors

Rawda Hesham Abd ElAziz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
17 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with carious proximal cavities in molars * Good oral hygiene. * Presence of favorable occlusion and teeth are in normal contact with the adjacent teeth.

Exclusion criteria

* Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis. * Severe periodontal problems.

Design outcomes

Primary

MeasureTime frameDescription
Clinical performanceChange from baseline at 6, 12 monthsPost operative Hypersensitivity, Secondary caries, Gross fracture, Cavo-surface marginal discoloration, Proximal contact. All these outcomes are measured by a score Alpha is excellent, Bravo is acceptable, Charlie is not accepted

Countries

Egypt

Contacts

Primary ContactRawda Hesham Hesham A.ElAziz
rawda.hesham@dentistry.cu.edu.eg+201001097200
Backup ContactDina Ezz Eldin Mohamed
Dina.ezz@dentistry.cu.edu.eg+20 100 800 7157

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026